Whether there are differences in the pathophysiological action of these two cytokines in RA or a switch-on role of early relapse in RA needs to be elucidated; patients with a high baseline IFNβ/α ratio showed poorer response to TNF inhibitors in RA23. This evidence concerns the gene TNF and rheumatoid arthritis.